☰

Andrew J. McDougal, Ph.D. - Publications

Affiliations: 
2000 Texas A & M University, College Station, TX, United States 
Area:
Toxicology, Oncology
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2002 Duan R, Xie W, Li X, McDougal A, Safe S. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochemical and Biophysical Research Communications. 294: 384-94. PMID 12051724 DOI: 10.1016/S0006-291X(02)00499-0  0.576
2002 Safe S, McDougal A. Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review). International Journal of Oncology. 20: 1123-8. PMID 12011988 DOI: 10.3892/Ijo.20.6.1123  0.688
2001 McDougal A, Gupta MS, Morrow D, Ramamoorthy K, Lee JE, Safe SH. Methyl-substituted diindolylmethanes as inhibitors of estrogen-induced growth of T47D cells and mammary tumors in rats. Breast Cancer Research and Treatment. 66: 147-57. PMID 11437101 DOI: 10.1023/A:1010608000074  0.661
2000 McDougal A, Sethi Gupta M, Ramamoorthy K, Sun G, Safe SH. Inhibition of carcinogen-induced rat mammary tumor growth and other estrogen-dependent responses by symmetrical dihalo-substituted analogs of diindolylmethane. Cancer Letters. 151: 169-79. PMID 10738111 DOI: 10.1016/S0304-3835(99)00406-1  0.692
1999 Safe S, Qin C, McDougal A. Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer. Expert Opinion On Investigational Drugs. 8: 1385-96. PMID 15992156 DOI: 10.1517/13543784.8.9.1385  0.674
1999 Ramamoorthy K, Gupta MS, Sun G, McDougal A, Safe SH. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells. Carcinogenesis. 20: 115-23. PMID 9934858 DOI: 10.1093/Carcin/20.1.115  0.719
1998 Gupta M, McDougal A, Safe S. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 67: 413-9. PMID 10030690 DOI: 10.1016/S0960-0760(98)00135-6  0.576
1998 Safe S, Wang F, Porter W, Duan R, McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicology Letters. 102: 343-7. PMID 10022276 DOI: 10.1016/S0378-4274(98)00331-2  0.688
1998 Chen I, McDougal A, Wang F, Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis. 19: 1631-9. PMID 9771935 DOI: 10.1093/Carcin/19.9.1631  0.71
1998 McDougal A, Safe S. Induction of 16alpha-/2-hydroxyestrone metabolite ratios in MCF-7 cells by pesticides, carcinogens, and antiestrogens does not predict mammary carcinogens. Environmental Health Perspectives. 106: 203-6. PMID 9494123 DOI: 10.1289/Ehp.98106203  0.457
1997 McDougal A, Wilson C, Safe S. Induction of estradiol 2-hydroxylase activity in MCF-7 human breast cancer cells by pesticides and carcinogens. Environmental Toxicology and Pharmacology. 3: 195-9. PMID 21781778 DOI: 10.1016/S1382-6689(97)00013-6  0.585
1997 McDougal A, Wilson C, Safe S. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. Cancer Letters. 120: 53-63. PMID 9570386 DOI: 10.1016/S0304-3835(97)00299-1  0.578
1997 Safe SH, McDougal A. Environmental factors and breast cancer Endocrine Related Cancer. 4: 113-123. DOI: 10.1677/Erc.0.0040113  0.526
Show low-probability matches.